Takeshi Harada

14PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Te ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Metabolic medicineAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 13, 2026
Selection of anti-CD38 antibodies for flow cytometric detection of myeloma cells treated with daratumumab or isatuximab.

Yusuke Inoue, Takeshi Harada, Asuka Oda

|Apr 02, 2026
IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs.

Yasuyo Ohguchi, Masahiko Ajiro, Daisuke Ogiya

|Jul 29, 2025
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.

Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto

|Jul 12, 2025
Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or Older.

Yousuke Kaneko, Yutaka Kawano, Saki Kawata

|Apr 25, 2025
False-Positive Galactomannan Test Results in Multiple Myeloma.

Shingen Nakamura, Yusaku Maeda, Ryohei Sumitani

|Nov 18, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.

Yusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi

Pageof 3

Frequent Collaborators

7 joint publications

Shingen Nakamura

5 joint publications

Ken-Ichi Aihara

4 joint publications

Itsuro Endo

4 joint publications

Toshiki Otoda